AUPP547398A0 - Predictive assessment of certain skeletal disorders - Google Patents

Predictive assessment of certain skeletal disorders

Info

Publication number
AUPP547398A0
AUPP547398A0 AUPP5473A AUPP547398A AUPP547398A0 AU PP547398 A0 AUPP547398 A0 AU PP547398A0 AU PP5473 A AUPP5473 A AU PP5473A AU PP547398 A AUPP547398 A AU PP547398A AU PP547398 A0 AUPP547398 A0 AU PP547398A0
Authority
AU
Australia
Prior art keywords
skeletal disorders
predictive assessment
certain skeletal
certain
predictive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP5473A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Priority to AUPP5473A priority Critical patent/AUPP547398A0/en
Publication of AUPP547398A0 publication Critical patent/AUPP547398A0/en
Priority to PCT/AU1999/000697 priority patent/WO2000013024A1/en
Priority to AU57209/99A priority patent/AU5720999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AUPP5473A 1998-08-26 1998-08-26 Predictive assessment of certain skeletal disorders Abandoned AUPP547398A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP5473A AUPP547398A0 (en) 1998-08-26 1998-08-26 Predictive assessment of certain skeletal disorders
PCT/AU1999/000697 WO2000013024A1 (en) 1998-08-26 1999-08-26 Predictive assessment of certain skeletal disorders
AU57209/99A AU5720999A (en) 1998-08-26 1999-08-26 Predictive assessment of certain skeletal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP5473A AUPP547398A0 (en) 1998-08-26 1998-08-26 Predictive assessment of certain skeletal disorders

Publications (1)

Publication Number Publication Date
AUPP547398A0 true AUPP547398A0 (en) 1998-09-17

Family

ID=3809700

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP5473A Abandoned AUPP547398A0 (en) 1998-08-26 1998-08-26 Predictive assessment of certain skeletal disorders

Country Status (2)

Country Link
AU (1) AUPP547398A0 (en)
WO (1) WO2000013024A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002247004A1 (en) * 2001-01-19 2002-07-30 Cambridge Scientific, Inc. Methods of diagnosis and treatment of osteoporosis
JP2005528581A (en) * 2001-02-21 2005-09-22 ストライカー コーポレイション Measurement of cartilage degeneration and aging using bone morphogenetic proteins
US7160994B2 (en) 2002-03-28 2007-01-09 Trustees Of The University Of Pennsylvania Osteoclast-specific genes and proteins and uses thereof
US8067557B2 (en) 2002-03-28 2011-11-29 The Trustees Of The University Of Pennsylvania OCL-2A3 compositions and uses thereof
GB0517466D0 (en) * 2005-08-26 2005-10-05 Immunodiagnostic Systems Plc Diagnostic assay and therapeutic treatment
JP5010034B2 (en) 2007-12-28 2012-08-29 エフ．ホフマン−ラ ロシュ アーゲー Physiological status assessment
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
GB201302257D0 (en) 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
KR102617833B1 (en) 2016-05-06 2023-12-27 엑시큐어 오퍼레이팅 컴퍼니 Liposomal spherical nucleic acid (SNA) construct presenting antisense oligonucleotides (ASO) for specific knockdown of interleukin 17 receptor mRNA
US11696954B2 (en) 2017-04-28 2023-07-11 Exicure Operating Company Synthesis of spherical nucleic acids using lipophilic moieties
CN108802379B (en) * 2018-06-14 2021-04-16 北京市心肺血管疾病研究所 Group of molecular markers for judging aortic dissection prognosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE161543T1 (en) * 1992-01-31 1998-01-15 David Jeston Baylink AMINOTERMINAL PROCOLLAGEN 1(I) PEPTIDES
EP0557663B1 (en) * 1992-02-27 1997-05-02 Delmas, Pierre, Dr. Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
GB9610281D0 (en) * 1996-05-16 1996-07-24 Ralston Stuart H Diagnostic method and apparatus
AU4152097A (en) * 1996-08-16 1998-03-06 Metra Biosystems, Inc. Method and kit for assessing bone resorption

Also Published As

Publication number Publication date
WO2000013024A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
IL142490A0 (en) ENZYMATIC SYNTHESIS OF ssDNA
AU6330199A (en) Electrochemical synthesis of perfluoroalkylfluorophosphoranes
AU8963698A (en) Prosthesis of the spinal column
AU6465798A (en) Diagnosing neurologic disorders
AU5235299A (en) Spectral topography of mammalian matter
AU6143998A (en) Regulators of apoptosis
AUPP547398A0 (en) Predictive assessment of certain skeletal disorders
AUPP618398A0 (en) Threaded fasteners
AU2217797A (en) Synthesis of indolylmaleimides
AU5437699A (en) Threaded fastener
AU4157097A (en) Synthesis of bisindolylmalimides
AU6110199A (en) Analysis of mixtures
AU5720999A (en) Predictive assessment of certain skeletal disorders
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats
AU5888698A (en) Refining element
GB9722451D0 (en) The manufacture of gaskets
AU3962999A (en) The method of microobjects' study
GB9711680D0 (en) Enzymatic synthesis
AU2481299A (en) Bridge press
AU2629599A (en) Purification of tramadol
TW370915U (en) Structure of wrench
AU2392600A (en) Synthesis of bisphenols
AU7974798A (en) New human lysophospholipase
AU2580299A (en) Synthesis of dysidiolide and uses thereof
AU2491899A (en) Synthesis of n-silylated cyclopentaphenanthrene compounds

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 5720999

Country of ref document: AU